VolitionRx Limited Research and Development Expense
VolitionRx Limited (VNRX) reported Research and Development Expense of $1.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- VolitionRx Limited research and development expense for the quarter ending 2026-06-30 was $1.80M, a 33.80% decline year-over-year.
- VolitionRx Limited research and development expense for the quarter ending 2026-03-31 was $2.85M, a 9.39% increase year-over-year.
- VolitionRx Limited research and development expense for the quarter ending 2025-12-31 was $2.47M, a 4.61% decline year-over-year.
- VolitionRx Limited research and development expense for the quarter ending 2025-09-30 was $2.29M, a 34.20% decline year-over-year.
- VolitionRx Limited research and development expense for fiscal 2025 was $10.08M, a 30.02% decline from fiscal 2024.
- VolitionRx Limited research and development expense for fiscal 2024 was $14.41M, a 26.32% decline from fiscal 2023.
- VolitionRx Limited research and development expense for fiscal 2023 was $19.55M, a 27.51% increase from fiscal 2022.
- VolitionRx Limited research and development expense for fiscal 2022 was $15.33M, a 17.74% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 17 month | Research and Development Expense 20 month | Research and Development Expense 23 month | Research and Development Expense 26 month | Research and Development Expense 29 month | Research and Development Expense 32 month | Research and Development Expense 35 month | Research and Development Expense 38 month | Research and Development Expense 41 month | Research and Development Expense 44 month | Research and Development Expense 47 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.80M 10-Q · filed 2026-08-13 | $4.65M 10-Q · filed 2026-08-13 | $7.12M derived: sum of 3 quarters · filed 2026-08-13 | $9.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | $2.85M 10-Q · filed 2026-05-14 | $5.32M derived: sum of 2 quarters · filed 2026-05-14 | $7.61M derived: sum of 3 quarters · filed 2026-05-14 | $10.33M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.75M derived: sum of 2 quarters · filed 2026-03-31 | $7.47M derived: sum of 3 quarters · filed 2026-08-13 | $10.08M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2025-09-30 | $2.29M 10-Q · filed 2025-11-13 | $5.01M derived: sum of 2 quarters · filed 2026-08-13 | $7.61M 10-Q · filed 2025-11-13 | $10.20M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | $2.72M 10-Q · filed 2026-08-13 | $5.33M 10-Q · filed 2026-08-13 | $7.92M derived: sum of 3 quarters · filed 2026-08-13 | $11.39M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | $2.61M 10-Q · filed 2026-05-14 | $5.19M derived: sum of 2 quarters · filed 2026-05-14 | $8.67M derived: sum of 3 quarters · filed 2026-05-14 | $12.38M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||||||
| 2024-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $6.06M derived: sum of 2 quarters · filed 2026-03-31 | $9.78M derived: sum of 3 quarters · filed 2026-03-31 | $14.41M 10-K · filed 2026-03-31 | ||||||||||||||||
| 2024-09-30 | $3.47M 10-Q · filed 2025-11-13 | $7.19M derived: sum of 2 quarters · filed 2025-11-13 | $11.82M 10-Q · filed 2025-11-13 | $16.36M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||||||
| 2024-06-30 | $3.72M 10-Q · filed 2025-08-14 | $8.35M 10-Q · filed 2025-08-14 | $12.89M derived: sum of 3 quarters · filed 2025-08-14 | $17.54M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||||||
| 2024-03-31 | $4.63M 10-Q · filed 2025-05-15 | $9.17M derived: sum of 2 quarters · filed 2025-05-15 | $13.82M derived: sum of 3 quarters · filed 2025-05-15 | $19.28M derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||||||
| 2023-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.19M derived: sum of 2 quarters · filed 2025-03-31 | $14.65M derived: sum of 3 quarters · filed 2025-03-31 | $19.55M 10-K · filed 2025-03-31 | ||||||||||||||||
| 2023-09-30 | $4.65M 10-Q · filed 2024-11-14 | $10.10M derived: sum of 2 quarters · filed 2024-11-14 | $15.01M 10-Q · filed 2024-11-14 | $19.14M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||||||
| 2023-06-30 | $5.45M 10-Q · filed 2024-08-14 | $10.36M 10-Q · filed 2024-08-14 | $14.49M derived: sum of 3 quarters · filed 2024-08-14 | $18.49M derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||||||
| 2023-03-31 | $4.91M 10-Q · filed 2024-05-13 | $9.04M derived: sum of 2 quarters · filed 2024-05-13 | $13.04M derived: sum of 3 quarters · filed 2024-05-13 | $16.32M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||||
| 2022-12-31 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $8.13M derived: sum of 2 quarters · filed 2024-03-25 | $11.41M derived: sum of 3 quarters · filed 2024-03-25 | $15.33M 10-K · filed 2024-03-25 | $14.57M 10-K · filed 2023-03-15 | |||||||||||||||
| 2022-09-30 | $4.00M 10-Q · filed 2023-11-14 | $3.74M 10-Q · filed 2022-11-14 | $7.28M derived: sum of 2 quarters · filed 2023-11-14 | $11.20M 10-Q · filed 2023-11-14 | $10.61M 10-Q · filed 2022-11-14 | $14.17M derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||||
| 2022-06-30 | $3.28M 10-Q · filed 2023-08-14 | $6.87M 10-Q · filed 2023-08-14 | $10.17M derived: sum of 3 quarters · filed 2023-08-14 | $13.78M derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||||||
| 2022-03-31 | $3.59M 10-Q · filed 2023-05-10 | $6.89M derived: sum of 2 quarters · filed 2023-05-10 | $10.50M derived: sum of 3 quarters · filed 2023-05-10 | $13.44M derived: sum of 4 quarters · filed 2023-05-10 | ||||||||||||||||
| 2021-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $6.91M derived: sum of 2 quarters · filed 2023-03-15 | $9.85M derived: sum of 3 quarters · filed 2023-03-15 | $13.02M 10-K · filed 2023-03-15 | $15.54M 10-K · filed 2022-03-30 | |||||||||||||||
| 2021-09-30 | $3.61M 10-Q · filed 2022-11-14 | $4.45M 10-Q · filed 2021-11-10 | $6.55M derived: sum of 2 quarters · filed 2022-11-14 | $9.72M 10-Q · filed 2022-11-14 | $11.97M 10-Q · filed 2021-11-10 | $14.39M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||||
| 2021-06-30 | $2.94M 10-Q · filed 2022-08-10 | $3.65M 10-Q · filed 2021-08-11 | $7.52M 10-Q · filed 2022-08-10 | $10.77M derived: sum of 3 quarters · filed 2022-08-10 | $13.95M derived: sum of 4 quarters · filed 2022-08-10 | |||||||||||||||
| 2021-03-31 | $3.87M 10-Q · filed 2022-05-11 | $7.84M derived: sum of 2 quarters · filed 2022-05-11 | $11.02M derived: sum of 3 quarters · filed 2022-05-11 | $14.51M derived: sum of 4 quarters · filed 2022-05-11 | ||||||||||||||||
| 2020-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $7.15M derived: sum of 2 quarters · filed 2022-03-30 | $10.64M derived: sum of 3 quarters · filed 2022-03-30 | $14.53M 10-K · filed 2022-03-30 | ||||||||||||||||
| 2020-09-30 | $3.18M 10-Q · filed 2021-11-10 | $6.67M derived: sum of 2 quarters · filed 2021-11-10 | $10.57M 10-Q · filed 2021-11-10 | $13.34M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||||
| 2020-06-30 | $3.49M 10-Q · filed 2021-08-11 | $7.39M 10-Q · filed 2021-08-11 | $10.15M derived: sum of 3 quarters · filed 2021-08-11 | $12.80M derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||||||
| 2020-03-31 | $3.89M 10-Q · filed 2021-05-11 | $6.66M derived: sum of 2 quarters · filed 2021-05-11 | $9.30M derived: sum of 3 quarters · filed 2021-05-11 | $11.78M derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||||||
| 2019-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $5.41M derived: sum of 2 quarters · filed 2021-03-22 | $7.89M derived: sum of 3 quarters · filed 2021-03-22 | $10.36M 10-K · filed 2021-03-22 | ||||||||||||||||
| 2019-09-30 | $2.64M 10-Q · filed 2020-11-12 | $5.12M derived: sum of 2 quarters · filed 2020-11-12 | $7.60M 10-Q · filed 2020-11-12 | $10.66M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||||||||||
| 2019-06-30 | $2.48M 10-Q · filed 2020-08-13 | $4.95M 10-Q · filed 2020-08-13 | $8.01M derived: sum of 3 quarters · filed 2020-08-13 | $10.75M derived: sum of 4 quarters · filed 2020-08-13 | ||||||||||||||||
| 2019-03-31 | $2.47M 10-Q · filed 2020-05-07 | $5.53M derived: sum of 2 quarters · filed 2020-05-07 | $8.27M derived: sum of 3 quarters · filed 2020-05-07 | $10.96M derived: sum of 4 quarters · filed 2020-05-07 | ||||||||||||||||
| 2018-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $5.80M derived: sum of 2 quarters · filed 2020-02-20 | $8.48M derived: sum of 3 quarters · filed 2020-02-20 | $10.91M 10-K · filed 2020-02-20 | ||||||||||||||||
| 2018-09-30 | $2.74M 10-Q · filed 2019-11-12 | $5.42M derived: sum of 2 quarters · filed 2019-11-12 | $7.85M 10-Q · filed 2019-11-12 | $10.25M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||||
| 2018-06-30 | $2.69M 10-Q · filed 2019-08-12 | $5.11M 10-Q · filed 2019-08-12 | $7.52M derived: sum of 3 quarters · filed 2019-08-12 | $9.65M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||||
| 2018-03-31 | $2.42M 10-Q · filed 2019-05-08 | $4.83M derived: sum of 2 quarters · filed 2019-05-08 | $6.96M derived: sum of 3 quarters · filed 2019-05-08 | $8.77M derived: sum of 4 quarters · filed 2019-05-08 | ||||||||||||||||
| 2017-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $4.54M derived: sum of 2 quarters · filed 2019-03-13 | $6.35M derived: sum of 3 quarters · filed 2019-03-13 | $8.03M 10-K · filed 2019-03-13 | $8.91M 10-K · filed 2018-03-01 | |||||||||||||||
| 2017-09-30 | $2.13M 10-Q · filed 2018-11-07 | $2.20M 10-Q · filed 2017-11-09 | $3.94M derived: sum of 2 quarters · filed 2018-11-07 | $5.62M 10-Q · filed 2018-11-07 | $5.77M 10-Q · filed 2017-11-09 | $8.33M derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||||
| 2017-06-30 | $1.81M 10-Q · filed 2018-08-13 | $1.73M 10-Q · filed 2017-08-10 | $3.48M 10-Q · filed 2018-08-13 | $3.57M 10-Q · filed 2017-08-10 | $6.20M derived: sum of 3 quarters · filed 2018-08-13 | $8.17M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | $1.67M 10-Q · filed 2018-05-10 | $1.84M 10-Q · filed 2017-05-11 | $4.39M derived: sum of 2 quarters · filed 2018-05-10 | $6.36M derived: sum of 3 quarters · filed 2018-05-10 | $8.11M derived: sum of 4 quarters · filed 2018-05-10 | |||||||||||||||
| 2016-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $4.69M derived: sum of 2 quarters · filed 2018-03-01 | $6.44M derived: sum of 3 quarters · filed 2018-03-01 | $7.90M 10-K · filed 2018-03-01 | $6.84M 10-K · filed 2017-03-10 | |||||||||||||||
| 2016-09-30 | $1.97M 10-Q · filed 2017-11-09 | $1.99M 10-Q · filed 2016-11-10 | $3.72M derived: sum of 2 quarters · filed 2017-11-09 | $5.18M 10-Q · filed 2017-11-09 | $5.25M 10-Q · filed 2016-11-10 | $6.85M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||
| 2016-06-30 | $1.75M 10-Q · filed 2017-08-10 | $1.79M 10-Q · filed 2016-08-11 | $3.21M 10-Q · filed 2017-08-10 | $3.25M 10-Q · filed 2016-08-11 | $4.88M derived: sum of 3 quarters · filed 2017-08-10 | $6.75M derived: sum of 4 quarters · filed 2017-08-10 | ||||||||||||||
| 2016-03-31 | $1.46M 10-Q · filed 2017-05-11 | $3.13M derived: sum of 2 quarters · filed 2017-05-11 | $5.00M derived: sum of 3 quarters · filed 2017-05-11 | $6.35M derived: sum of 4 quarters · filed 2017-05-11 | ||||||||||||||||
| 2015-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $3.53M derived: sum of 2 quarters · filed 2017-03-10 | $4.89M derived: sum of 3 quarters · filed 2017-03-10 | $6.10M 10-K · filed 2017-03-10 | ||||||||||||||||
| 2015-09-30 | $1.86M 10-Q · filed 2016-11-10 | $3.22M derived: sum of 2 quarters · filed 2016-11-10 | $4.43M 10-Q · filed 2016-11-10 | $5.74M derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||||||||
| 2015-06-30 | $1.36M 10-Q · filed 2016-08-11 | $2.57M 10-Q · filed 2016-08-11 | $3.88M derived: sum of 3 quarters · filed 2016-08-11 | $4.95M derived: sum of 4 quarters · filed 2016-08-11 | ||||||||||||||||
| 2015-03-31 | $1.21M 10-Q · filed 2016-05-13 | $2.52M derived: sum of 2 quarters · filed 2016-05-13 | $3.59M derived: sum of 3 quarters · filed 2016-05-13 | $4.38M derived: sum of 4 quarters · filed 2016-05-13 | ||||||||||||||||
| 2014-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $2.38M derived: sum of 2 quarters · filed 2016-03-11 | $3.17M derived: sum of 3 quarters · filed 2016-03-11 | $4.04M 10-K · filed 2016-03-11 | ||||||||||||||||
| 2014-09-30 | $1.07M 10-Q · filed 2015-11-04 | $1.86M derived: sum of 2 quarters · filed 2015-11-04 | $2.73M 10-Q · filed 2015-11-04 | $3.48M derived: sum of 4 quarters · filed 2015-11-04 | ||||||||||||||||
| 2014-06-30 | $791.29K 10-Q · filed 2015-08-11 | $1.66M 10-Q · filed 2015-08-11 | $2.41M derived: sum of 3 quarters · filed 2015-08-11 | $2.93M derived: sum of 4 quarters · filed 2015-08-11 | $8.63M 10-Q · filed 2014-08-01 | |||||||||||||||
| 2014-03-31 | $870.46K 10-Q · filed 2015-05-12 | $1.62M derived: sum of 2 quarters · filed 2015-05-12 | $2.14M derived: sum of 3 quarters · filed 2015-05-12 | $2.78M derived: sum of 4 quarters · filed 2015-05-12 | $7.84M 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $745.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $1.27M derived: sum of 2 quarters · filed 2015-03-18 | $1.91M derived: sum of 3 quarters · filed 2015-03-18 | $2.50M 10-K · filed 2015-03-18 | $6.97M 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $524.53K 10-Q · filed 2014-11-06 | $1.17M derived: sum of 2 quarters · filed 2014-11-06 | $1.76M 10-Q · filed 2014-11-06 | $2.83M derived: sum of 4 quarters · filed 2014-11-06 | $6.22M 10-Q · filed 2013-10-31 | |||||||||||||||
| 2013-06-30 | $640.64K 10-Q · filed 2014-08-01 | $1.23M 10-Q · filed 2014-08-01 | $2.30M derived: sum of 3 quarters · filed 2014-08-01 | $2.94M derived: sum of 4 quarters · filed 2014-08-01 | $5.70M 10-Q · filed 2013-07-29 | |||||||||||||||
| 2013-03-31 | $593.20K 10-Q · filed 2014-05-15 | $1.66M derived: sum of 2 quarters · filed 2014-05-15 | $2.30M derived: sum of 3 quarters · filed 2014-05-15 | $2.86M derived: sum of 4 quarters · filed 2014-05-15 | $5.17M 10-Q · filed 2013-05-06 | |||||||||||||||
| 2012-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.70M derived: sum of 2 quarters · filed 2014-03-28 | $2.26M derived: sum of 3 quarters · filed 2014-03-28 | $2.77M 10-K · filed 2014-03-28 | $2.84M 10-K · filed 2013-04-01 | $4.54M 10-K · filed 2013-04-01 | ||||||||||||||
| 2012-09-30 | $633.80K 10-Q · filed 2013-10-31 | $663.88K 10-Q · filed 2012-11-14 | $1.19M derived: sum of 2 quarters · filed 2013-10-31 | $1.70M 10-Q · filed 2013-10-31 | $1.73M 10-Q · filed 2012-11-14 | $2.32M derived: sum of 4 quarters · filed 2013-10-31 | $3.43M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $559.43K 10-Q · filed 2013-07-29 | $1.07M 10-Q · filed 2013-07-29 | $1.68M derived: sum of 3 quarters · filed 2013-07-29 | $1.97M derived: sum of 4 quarters · filed 2013-07-29 | $2.76M 10-Q · filed 2012-08-14 | |||||||||||||||
| 2012-03-31 | $511.05K 10-Q · filed 2013-05-06 | $502.67K 10-Q · filed 2012-05-15 | $1.12M derived: sum of 2 quarters · filed 2013-05-06 | $1.41M derived: sum of 3 quarters · filed 2013-05-06 | $1.83M derived: sum of 4 quarters · filed 2013-05-06 | $2.18M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | $611.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $903.32K derived: sum of 2 quarters · filed 2013-04-01 | $1.32M derived: sum of 3 quarters · filed 2013-04-01 | $1.52M 10-K · filed 2013-04-01 | $1.51M 10-KT/A · filed 2012-05-08 | $1.68M 10-KT/A · filed 2012-05-08 | ||||||||||||||
| 2011-09-30 | $292.20K 10-Q · filed 2012-11-14 | $707.72K derived: sum of 2 quarters · filed 2012-11-14 | $909.93K 10-Q · filed 2012-11-14 | |||||||||||||||||
| 2011-06-30 | $415.52K 10-Q · filed 2012-08-14 | $617.72K 10-Q · filed 2012-08-14 | ||||||||||||||||||
| 2011-03-31 | $198.08K 10-Q · filed 2012-05-15 | |||||||||||||||||||
| 2010-12-31 | $172.19K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |